Scancell Share Discussion Threads

[bermudashorts] 23/4/2018 10:46

Agema - do you think a loan would have been a better option?

[inanaco] 23/4/2018 10:45

Agema

Nothing to stop you getting up to speed on the science

Gazza suggested he could do it in 4 hrs .. mind you scant evidence of that ...

[agema] 23/4/2018 10:36

J777

Yes. A 13p a share company that has just placed 31% below market value can easily emulate a 3.5 billion market cap company. Lol.

Inanaco

Yes Scancell have a credit line open. That’s why they choose not to borrow at a few percent interest and chose to place at 31% discount instead. Lol.

[the real lozan] 23/4/2018 10:32

Gash - 15266
Like it - VERY subtle
A little TOO subtle for the HERO worshipers... methinks

[panama7] 23/4/2018 10:23

777, why on earth would we need to further fund raise in the U.S when we are going to be signing all these deals and CH is going to moneytise our assets in the near to short term.

[j777j] 23/4/2018 10:22

Oh and 're what has it.got to do with GW pharma?GW pharma multibagged from Aim to Nasdaq.Scancell with it's extraordinary platforms could easily do the same.

[inanaco] 23/4/2018 10:20

Like i have said before, Lindy is always ahead of us on the science, as legal paperwork prevents disclosure ....

The Grand Challenge i suggest will bring all this technology into focus against the hardest to treat cancers ...

The fact that the main players are linked scientifically goes along way into verifying
that the collabortion with BioNtech will end with a money on the table, for the reason that this Group has presented the science to CRUK .... can't be that bad its in the top 10 for the money ..

Agema your days of posting just like Loz on the funding is coming to an End ...

at some point you need to buy in, because i suggest this could be the last cash call from the market, if that is so, self funding takes over.

You will also have a very good indication from the collaboration "value" as to the efficacy of Modi1 ....

after all its the contents of that vaccine, that is under investigation ...

[gazza] 23/4/2018 10:17

TF, thanks for correcting that. We wouldn't want to put off any new potential investors. Atb

[j777j] 23/4/2018 10:15

Clinical trials will take place in the US.100% that is where the next fundraising will take place.Scnlf is not what I am talking.about.Some sort of Nasdaq listing is.

[inanaco] 23/4/2018 10:05

Thing is TF anyone up to it can join in those posts ...what i try to do is curtail generalisations, because that indicates to me the writer does not have the capacity to discuss Scancell ... so easy to quash negatives

Agema keeps going on about Big Pharma .. no deals but fails to understand the depth of "skill" CRUK have ... and they have chosen scancell

ISA pharma value Scancell in effect we have a credit line with them. Coupled with BioNtech desire to get hold of the epitopes, and Scancells desire to get max value from them, we have a collaboration to identify just how valuable they are

valuing 3 we have 37 so far

The Full effects of moditope and immunobody potential is still to be unleashed

And i suggest these sugar targets could be very very interesting because of the versatility of the MABs in the way they can function. Especially bispecfic function

hxxps://immatics.com/tcr-bispecifics.html

[mikethebike4] 23/4/2018 10:01

J777J23 Apr '18 - 08:18 - 15251 of 15260

Interesting to note Bank of New York Mellon own 5.68% as trustee.

No doubt in my mind there will be a secondary listing in the US.

Did wonders for GW pharma.

- try SCNLF

[the real lozan] 23/4/2018 09:55

"And the brilliant stuff is elsewhere. ATB"
.
As is the £6

[agema] 23/4/2018 09:41

Bermudashorts

Tom is like me. Tells it as he see it. He owns Scancell shares, but is not confident nowadays. But continues to hold on the off chance.

How can it be positive when clearly no Majors are prepared to put money into Scancell.

[bermudashorts] 23/4/2018 09:36

Agema - re. your 15249 - in other words covering all options. Easy if you just sit on the fence and spout generalisations.

[agema] 23/4/2018 09:09

J777

You made the link. But as Bermuda pointed out to you, even that was wrong. Now that is stupid.

[bermudashorts] 23/4/2018 08:56

J777 - although the 5.68% are held by BNY, they're owned by City Financial (Absolute Equity Fund)

[j777j] 23/4/2018 08:44

Are you that stupid?

[agema] 23/4/2018 08:38

Post 15251.

Bit silly comparing GW pharma to Scancell. Lol. GW pharma has a mkt cap of over 3.5 Billion. Lol.

[j777j] 23/4/2018 08:18

Interesting to note Bank of New York Mellon own 5.68% as trustee.No doubt in my mind there will be a secondary listing in the US.Did wonders for GW pharma.